Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Sinovac Biotech Ltd. (NASDAQ: SVA).

Full DD Report for SVA

You must become a subscriber to view this report.


Recent News from (NASDAQ: SVA)

SEC Concludes Investigation of Sinovac
BEIJING , Aug. 20, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China , today announced that the U.S. Securities and Exchange Commission ("SEC") has concluded its investigation into possible viol...
Source: PR Newswire
Date: August, 20 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-147.297.397.457.23529,007
2017-03-105.985.946.005.945,250
2017-03-095.955.956.025.87133,752
2017-03-085.625.935.955.6076,776
2017-03-075.755.605.805.502,985,118

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-075852,01828.9891Cover
2018-12-062621,03225.3876Cover
2018-12-043,99411,34735.1987Short
2018-12-039141,96346.5614Short
2018-11-302861,01828.0943Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SVA.


About Sinovac Biotech Ltd. (NASDAQ: SVA)

Logo for Sinovac Biotech Ltd. (NASDAQ: SVA)

Not available

 

Contact Information

 

 

Current Management

  • Wei Dong Yin / President

Current Share Structure

  • Market Cap: $429,868,678 - 05/18/2018
  • Issue and Outstanding: 57,011,761 - 12/31/2016

 


Recent Filings from (NASDAQ: SVA)

Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: August, 27 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 20 2018
Amendment to the schedule
Filing Type: SC 13E3/AFiling Source: edgar
Filing Date: July, 23 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: July, 20 2018
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Type: SC 13DFiling Source: edgar
Filing Date: July, 11 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: July, 10 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: July, 03 2018
Amendment to a previously filed 8-A12B
Filing Type: 8-A12B/AFiling Source: edgar
Filing Date: July, 03 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 26 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 11 2018

 

 


Daily Technical Chart for (NASDAQ: SVA)

Daily Technical Chart for (NASDAQ: SVA)


Stay tuned for daily updates and more on (NASDAQ: SVA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: SVA)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SVA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SVA and does not buy, sell, or trade any shares of SVA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/